DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,883 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,828,818 | -0.2% | 31,334 | -0.2% | 0.34% | -2.3% |
Q1 2024 | $7,844,203 | +10.2% | 31,412 | +2.0% | 0.35% | -0.3% |
Q4 2023 | $7,121,336 | -5.9% | 30,783 | +0.9% | 0.35% | -14.7% |
Q3 2023 | $7,567,554 | +6.8% | 30,502 | +3.3% | 0.42% | +8.1% |
Q2 2023 | $7,083,360 | -1.2% | 29,514 | +3.8% | 0.38% | -15.4% |
Q1 2023 | $7,168,768 | +2.3% | 28,443 | +7.7% | 0.45% | -1.9% |
Q4 2022 | $7,006,558 | +1.0% | 26,398 | -1.7% | 0.46% | -7.8% |
Q3 2022 | $6,937,000 | +2.5% | 26,857 | +0.6% | 0.50% | +8.2% |
Q2 2022 | $6,770,000 | -12.6% | 26,706 | +1.1% | 0.46% | -1.7% |
Q1 2022 | $7,748,000 | -12.0% | 26,416 | -1.3% | 0.47% | -8.5% |
Q4 2021 | $8,809,000 | +8.0% | 26,773 | -0.1% | 0.52% | -1.5% |
Q3 2021 | $8,160,000 | +11.0% | 26,803 | -2.2% | 0.52% | +8.7% |
Q2 2021 | $7,351,000 | +18.3% | 27,393 | -0.8% | 0.48% | +10.3% |
Q1 2021 | $6,215,000 | -0.8% | 27,614 | -2.1% | 0.44% | -9.7% |
Q4 2020 | $6,262,000 | +3.6% | 28,193 | +0.4% | 0.48% | -9.2% |
Q3 2020 | $6,046,000 | +24.5% | 28,075 | +2.3% | 0.53% | +17.1% |
Q2 2020 | $4,855,000 | +25.7% | 27,453 | -1.7% | 0.46% | +4.8% |
Q1 2020 | $3,863,000 | -7.0% | 27,914 | +3.1% | 0.43% | +17.3% |
Q4 2019 | $4,155,000 | +3.6% | 27,069 | -2.5% | 0.37% | -4.4% |
Q3 2019 | $4,009,000 | +2.1% | 27,761 | +1.0% | 0.39% | -2.8% |
Q2 2019 | $3,927,000 | +7.9% | 27,475 | -0.4% | 0.40% | +4.5% |
Q1 2019 | $3,641,000 | +28.2% | 27,579 | +0.2% | 0.38% | +14.4% |
Q4 2018 | $2,839,000 | -3.5% | 27,532 | +1.1% | 0.33% | -1.8% |
Q3 2018 | $2,941,000 | -43.2% | 27,236 | -48.1% | 0.34% | +2.1% |
Q2 2018 | $5,179,000 | +245.0% | 52,491 | +242.2% | 0.33% | -22.8% |
Q1 2018 | $1,501,000 | +2.2% | 15,341 | -3.1% | 0.43% | -25.2% |
Q4 2017 | $1,469,000 | +7.2% | 15,831 | -0.9% | 0.58% | +6.5% |
Q3 2017 | $1,370,000 | +4.9% | 15,970 | +3.2% | 0.54% | +0.2% |
Q2 2017 | $1,306,000 | -9.4% | 15,479 | -8.1% | 0.54% | -9.6% |
Q1 2017 | $1,441,000 | +16.8% | 16,846 | +6.2% | 0.60% | +9.2% |
Q4 2016 | $1,234,000 | -2.0% | 15,861 | -1.2% | 0.55% | +2.2% |
Q3 2016 | $1,259,000 | -27.3% | 16,057 | -6.3% | 0.53% | -29.9% |
Q2 2016 | $1,732,000 | -3.8% | 17,143 | -9.7% | 0.76% | -12.7% |
Q1 2016 | $1,801,000 | +3.6% | 18,994 | +1.4% | 0.87% | +0.8% |
Q4 2015 | $1,739,000 | +13.4% | 18,729 | +4.1% | 0.87% | -0.7% |
Q3 2015 | $1,533,000 | +10.2% | 17,991 | +10.7% | 0.87% | +24.4% |
Q2 2015 | $1,391,000 | +2.1% | 16,259 | +1.2% | 0.70% | +1.9% |
Q1 2015 | $1,363,000 | +6.2% | 16,061 | +7.3% | 0.69% | -10.8% |
Q4 2014 | $1,283,000 | – | 14,973 | – | 0.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |